GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Raphas Co Ltd (XKRX:214260) » Definitions » FCF Margin %

Raphas Co (XKRX:214260) FCF Margin % : 15.33% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Raphas Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Raphas Co's Free Cash Flow for the three months ended in Dec. 2023 was ₩1,311 Mil. Raphas Co's Revenue for the three months ended in Dec. 2023 was ₩8,555 Mil. Therefore, Raphas Co's FCF Margin % for the quarter that ended in Dec. 2023 was 15.33%.

As of today, Raphas Co's current FCF Yield % is -5.06%.

The historical rank and industry rank for Raphas Co's FCF Margin % or its related term are showing as below:

XKRX:214260' s FCF Margin % Range Over the Past 10 Years
Min: -159.25   Med: -24.33   Max: 22.11
Current: -21.72


During the past 10 years, the highest FCF Margin % of Raphas Co was 22.11%. The lowest was -159.25%. And the median was -24.33%.

XKRX:214260's FCF Margin % is ranked better than
68.79% of 1035 companies
in the Biotechnology industry
Industry Median: -149.8 vs XKRX:214260: -21.72


Raphas Co FCF Margin % Historical Data

The historical data trend for Raphas Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raphas Co FCF Margin % Chart

Raphas Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -51.79 -9.88 -5.05 -47.70 -21.72

Raphas Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.46 -38.45 -19.98 -59.91 15.33

Competitive Comparison of Raphas Co's FCF Margin %

For the Biotechnology subindustry, Raphas Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raphas Co's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Raphas Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Raphas Co's FCF Margin % falls into.



Raphas Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Raphas Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-6067.778/27935.888
=-21.72 %

Raphas Co's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=1311.228/8554.525
=15.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Raphas Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Raphas Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Raphas Co (XKRX:214260) Business Description

Traded in Other Exchanges
N/A
Address
62, Magokjungang 8-ro 1-gil, Gangseo-gu, Seoul, KOR, 07793
Raphas Co Ltd is engaged in the development of a drug delivery system. The company's products include Acropass, Cosmetics ODM, and Medical Contract Manufacturing Services. Its products are mostly used in biomedical products and all-natural cosmetic materials.

Raphas Co (XKRX:214260) Headlines

No Headlines